Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why These 5 Stocks Are Pulling the Market Down on Tuesday

At a time when the S&P 500 is off by 1.5%, shares of Axovant Sciences Ltd (NYSE:AXON), Ferrari N.V. (NYSE:RACE), Waddell & Reed Financial, Inc. (NYSE:WDR), Pitney Bowes Inc. (NYSE:PBI), and Citigroup Inc (NYSE:C) are off by considerably more. We’ll look into why investors are selling these stocks off at a discount and also examine relevant hedge fund sentiment towards them.

At Insider Monkey, we track around 730 hedge funds and institutional investors. Through extensive backtests, we have determined that imitating some of the stocks that these investors are collectively bullish on can help retail investors generate double digits of alpha per year. The key is to focus on the small-cap picks of these funds, which are usually less followed by the broader market and allow for larger price inefficiencies (see more details about our small-cap strategy).

At the top of our list is Axovant Sciences Ltd (NYSE:AXON), whose stock has fallen by 25% in afternoon trading after Pfizer Inc. (NYSE:PFE) terminated the phase II testing of PF-05212377, based on poor efficiency. The program was being developed for Alzheimer’s Disease and raises new concerns about the drug, which is also being tested in a separate Phase III trial.

During the third quarter, Axovant Sciences Ltd (NYSE:AXON) registered a decrease in popularity among the funds that we track, with 15 investors holding long positions at the end of September, versus 21 funds at the end of June, though they still amassed a gargantuan 88.4% of the float.

Follow Axovant Gene Therapies Ltd. (NASDAQ:AXGT)
Trade (NASDAQ:AXGT) Now!

Moving on, Ferrari N.V. (NYSE:RACE) shares are down by 12% today after the company reported disappointing fourth-quarter results. For its latest quarter, the exotic sports car company earned $0.28 per share on revenue of $744 million, missing estimates by $0.07 per share and $7.06 million, respectively. Total sales declined by 1% year-over-year. Shares of Ferrari are down by 27% since the company’s U.S IPO at the beginning of the year.

Waddell & Reed Financial, Inc. (NYSE:WDR) shares are down by around 15% today and touching a 52-week low. Analysts at Credit Suisse downgraded the company to ‘Underperform’ from ‘Neutral’ and also cut their price target on the stock to $28 per share from $33 per share, leading to the flight from the stock.

Among the funds we follow, 16 reported long positions in Waddell & Reed Financial, Inc. (NYSE:WDR) as of the end of September, down by three funds from a quarter earlier. Ken Fisher‘s Fisher Asset Management was the largest shareholder of the stock in our system, with 1.93 million shares valued at $67.04 million at the end of September.

Follow Waddell & Reed Financial Inc (NYSE:WDR)
Trade (NYSE:WDR) Now!

We have two more stocks to get to, which we’ll do on the following page.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.